Nancy E. Taylor

Nancy E. Taylor

Shareholder

Nancy Taylor is Co-Chair of the Health Care & FDA Practice and has advised clients on health and FDA related matters for more than two decades. She has broad experience in areas relating to the Affordable Care Act provisions, CMS reimbursement and policy issues relating to providers and plans, and she has done a significant amount of FDA regulatory work. Prior to joining Greenberg Traurig, Nancy served 10 years as Health Policy Director for the Senate Committee on Labor and Human Resources and worked on a number of significant health and FDA laws, including NLEA, Safe Medical Device Act, Hatch-Waxman, COBRA and ADA. She also served as CEO of a start-up medical device company, where she obtained eight product clearances, including securing reimbursement coverage for each product.

Concentrations

  • Food & Drug
  • Health care
  • Managed care
  • Regulatory interpretation on health care matters
Read More +

Capabilities

Experience

  • Represented Centre Partners in connection with its acquisition of Guy & O’Neill, Inc., a consumer products company that focuses on private label and contract manufacturing.
  • Advised major pharmaceutical, insurance, and health care providers and employers on various health care matters, including an evaluation of health care reform on their business practices and in resolving various legal and regulatory matters before Congress and Administrative agencies.
  • Involved in the development of a skilled nursing facility prospective payment system and home health care reimbursement issues. Also represented therapy and ancillary companies on reimbursement issues.
  • Experienced with issues relating to managed care laws, including Medicare risk and ERISA plan requirements.
  • Advised clients on the FDA approval process, principally medical devices, biologics and drug applications.
  • During her tenure on Capitol Hill, drafted and was instrumental in most major health care laws enacted during the past two decades, including the Safe Medical Devices Amendments of 1988, the Nutritional Labeling and Education Act of 1990, the Clinical Laboratory Improvement Act of 1988, COBRA (extension of health benefits) the Orphan Drug Amendments of 1983, the Americans with Disabilities Act (provisions relating to health care), and many other bills included in reconciliation or as freestanding health care.

Recognition & Leadership

  • Listed, Super Lawyers magazine, Washington, D.C. Super Lawyers, 2014-2018
  • Listed, The Legal 500 United States, 2013, 2015-2018
  • Selected,  "Life Science Star," LMG Life Sciences, 2012 and 2016-2018
  • Team Member, BTI Power Rankings, “The 16 Strongest Firms for ‘Go-To Outside Counsel’ Insurance Work,” 2016
  • Member, Winning Team, M&A Advisor Awards, "Healthcare and Life Sciences Deal of the Year (from $10mm to $500mm)" for the Chapter 11 sale of ATLS Acquisition, LLC, dba Liberty Medical Supply, Inc., 2015
  • Member, Winning Team, Global M&A Network’s Turnaround Atlas Awards, "Turnaround of the Year - Small Markets" for the restructuring and sale of ATLS Acquisition, LLC (dba Liberty Medical), 2015
  • Recipient, FDA Commissioner's Special Citation, Department of Health and Human Services, Public Health Service
  • Team Member, a U.S. News - Best Lawyers® "Government Relations Law Firm of the Year," 2014
  • Rated, AV Preeminent® 5.0 out of 5

°AV®, AV Preeminent®, Martindale-Hubbell DistinguishedSM and Martindale-Hubbell NotableSM are certification marks used under license in accordance with the Martindale-Hubbell® certification procedures, standards and policies.

  • Member, American Bar Association
  • Member, The Food and Drug Law Institute
  • Member, National Health Lawyers Association
  • Quality Board Member, Inova Fair Oaks Hospital

Credentials

Education
  • J.D., The Catholic University of America, Columbus School of Law, 1988
  • B.S., University of Utah, 1979
Admissions
  • District of Columbia